06/06/2025
5:03 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
5:04 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
3:25 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025
5:02 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2025
5:39 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
5:41 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
5:42 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
5:44 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:00 PM | Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:02 PM | BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:10 PM | Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TBPH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
05/21/2025
6:13 PM | GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:15 PM | MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:17 PM | O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:20 PM | PAKIANATHAN DEEPIKA (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:22 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
3:29 PM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
5:00 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
4:16 PM | Theravance Biopharma (Filer)
| Form DEF 14A | |
03/07/2025
5:15 AM | Theravance Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
5:17 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:07 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:09 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:11 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:05 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:24 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:26 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:28 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:30 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:32 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
5:05 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:04 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:06 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:08 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:09 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:10 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:08 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:53 AM | Madison Avenue Partners, LP (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
11/14/2024
5:06 AM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
7:42 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
2:33 PM | Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
11/04/2024
1:10 PM | Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/24/2024
3:44 PM | BlackRock, Inc. (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
09/23/2024
5:05 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
5:02 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:42 PM | BAUPOST GROUP LLC/MA (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
08/22/2024
7:03 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:05 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:06 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:07 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:09 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
5:02 PM | Samaha Eli (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
5:05 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:57 PM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2024
5:15 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy TBPH Stock Free TBPH Stock Alerts